S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK -7.14% Market Closed
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Revenue
kr3.8m
CAGR 3-Years
167%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Revenue
kr270.6B
CAGR 3-Years
26%
CAGR 5-Years
18%
CAGR 10-Years
12%
H Lundbeck A/S
CSE:HLUN A
Revenue
kr19.9B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Revenue
kr4.8B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Revenue?
Revenue
3.8m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Revenue amounts to 3.8m DKK.

What is Stenocare A/S's Revenue growth rate?
Revenue CAGR 5Y
-2%

Over the last year, the Revenue growth was -16%. The average annual Revenue growth rates for Stenocare A/S have been 167% over the past three years , -2% over the past five years .

Back to Top